ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SUN Surgical Innovations Group Plc

0.50
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.60 0.50 0.50 0.50 711,989 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 11.34M 264k 0.0003 16.67 4.66M
Surgical Innovations Group Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker SUN. The last closing price for Surgical Innovations was 0.50p. Over the last year, Surgical Innovations shares have traded in a share price range of 0.40p to 2.25p.

Surgical Innovations currently has 932,816,000 shares in issue. The market capitalisation of Surgical Innovations is £4.66 million. Surgical Innovations has a price to earnings ratio (PE ratio) of 16.67.

Surgical Innovations Share Discussion Threads

Showing 10201 to 10221 of 11925 messages
Chat Pages: Latest  417  416  415  414  413  412  411  410  409  408  407  406  Older
DateSubjectAuthorDiscuss
01/8/2017
08:07
Now now boys and girls

The point is for SUN worshippers

As a result of what has happened in the PAST

Elemental Healthcare got a contract from the NHS to act as an agent for the NHS to source suitable mesh products FOR NHS use

buywell3
31/7/2017
19:32
You do not have a clue
srichardson8
31/7/2017
16:29
My daughter is a senior registrar in obstetrics and gynaecology. She tells me there was a problem about ten years ago with 'bandits' using mesh in non-lapro operations. They are only now used in laparoscopic procedures, at least in the NHS in the UK.
srichardson8
31/7/2017
11:28
Just seen WHIreland increased target price to 6p
jmf69
31/7/2017
10:39
Targeting 5p by the end of the year
jmf69
31/7/2017
10:12
Looking good here, one to tuck away for a few years, I have been this year, buying dips.
ny boy
30/7/2017
22:40
Re posting...http://www.telegraph.co.uk/business/2017/02/19/british-firm-bid-make-surgical-superglue-stick/
jmf69
30/7/2017
18:59
“The mesh market is set to grow will post on that tomorrow”

I did not ask about market growth; I was referring to some disquiet and some reports have likened Mesh as the new thalidomide for women

With respect as ever
VZ

van zandt
28/7/2017
22:09
Wonder how the Surgical Dynamics integration is going and the MIMS production all in full flow?
jmf69
28/7/2017
16:34
gnnmartin

Last heard of on here Feb 2017

Are you still around I recall you were one of the few decent posters at that time





Because you agreed with most of the points I was raising .... which of course were valid

buywell3
28/7/2017
16:18
How many shares have you got now gbh2 ?

You sold over 2M at around 2p I seem to remember

Do you remember ?

I remember buying them at the time ...... ta

I am part elephant


gbh2 - 09 Sep 2015 - 07:53:14 - 3631 of 4052 (Surging) Surgical Innovations - SUN
I found (what turned out to be) better things to do with my cash, sold out ca 1.5p

17 years and quite a journey of highs & lows, no regrets, wish you well guys.



See I was there
buywell317 Sep '15 - 09:27 - 3637 of 4192 0 0 Edit
So r u now out of SUN gbh2 ?

r the results also out this week ?


And look who else was talking that time

mandate9 Sep '15 - 16:02 - 3632 of 4193 0 0
Still got 500k+. Like the product, let's hope they get their sales, marketing and distribution right this time around.


Well mandate it took them nearly 2 years , Nigel Rogers and a new BOD but SUN finally got the distribution bit you raised sorted

Now comes the marketing/sales which Elemental Healthcare will take care of

buywell3
28/7/2017
15:53
The company keeps employing local people, which imo is the best bit about it.
gbh2
28/7/2017
15:34
@gbh2 that's why you missed all of the good bits!
mandate
28/7/2017
15:22
Hope you're kidding mandate - I've had the Filter on every version of buywell for years !
gbh2
28/7/2017
14:53
We all think you are better than us at this research game!!!!
meijiman
28/7/2017
14:27
As always, buywell3, excellent overview/detail - thanks
mandate
28/7/2017
12:47
gbh2







Any chance you can flog yours ?


















Assuming you had any that is

buywell3
28/7/2017
07:39
Yes agreed NY Boy ... I like to see those BOD's putting their hands in their pocket or purse ... and buying their own company paper with it.

Note

That RNS does not include the extra shares that BOD members acquired in the placing

I expect some decent newsflow over the next few weeks

buywell3
28/7/2017
07:36
Yes indeed ! Bought in their SIPPs, no doubt as a medium to long term investment. This is at last looking a very good share, and to buy more at these levels will I'm sure look to have been great timing in 6-12 months time.
kenone
28/7/2017
07:27
Morning all...

Always a good sign...

Nigel Rogers, Executive Chairman, acquired 400,000 Ordinary Shares for his SIPP at a price of 3.49 pence per share. Following this transaction, Mr. Rogers' shareholding is 4,093,478 Ordinary Shares, representing 0.76% of the issued share capital.

ny boy
27/7/2017
20:26
The mesh market is set to grow will post on that tomorrow

Re microline below ......see this


Check it out and think


Surgical to buy NHS supplier in "natural next step"
Published: 16:55 Thursday 27 July 2017

​K​eyhole surgery instrument​s​ maker Surgical Innovations ​​is to buy ​​Elemental Healthcare​, ​​a̴3;n NHS medical products ​supplier,R03; ​for £9.4m​.​ ​Leeds-based Surgical​̴3; ​said Elemental is already well known to​ the firm as ​the exclusive distributor of SI branded products in the UK​. It said that​ the acquisition of a profitable and cash generative distributor is expected to have an immediate positive impact on Surgical’s ​margins and profitability.

​​Nigel Rogers, ​e​xecutive ​c​hairman of Surgical​, said: “Coming together was the natural next step for two businesses that have had such a long-standing and​ ​fruitful partnership​. ​​“Adam and David, the​ ​principals at Elemental, have a great pedigree in the medical device section and ​we ​look forward to benefiting​ ​from their insights into our new product initiatives and business development here and abroad.” Elemental is owned by co-founders Adam Power and David Marsh, who will both join the Board of Surgical​ ​Innovations ​​as ​g​roup ​d​evelopment ​d​irector and ​g​roup ​c​ommercial ​director, respectively.

The business​ ​employs 19 staff ​in Berkshire, including a sales team of 12. Surgical announced a ​p​lacing and ​s​ubscription to raise £5.5m at a placing price of 3p​ ​through stockbroker WH Ireland​ to help fund the deal.

The proceeds will be used to fund the acquisition, alongside existin​g ​cash resources and a new £2.5m debt facility with Yorkshire Bank. Surgical will pay a total of​ ​£7.5m in cash to ​Mr ​Power and ​Mr ​Marsh, as well ​as ​issuing them shares worth £1.875m, approximately 8​ per cent​ of the​ ​enlarged company.

The Surgical ​b​oard ha​s​ also invested in the fundrais​ing​, to the tune of £82,500 between​ ​them. ​

Mr Rogers said: “There are clear and obvious benefits to margins and​ ​earnings as we add a highly profitable and cash generative business to the group, but this also provides us with access to an experienced direct sales force and the new products distributed by Elemental will widen​ ​the range of products on offer to surgeons in the NHS and UK private hospitals. “All acquisitions have some integration risks attached to them, but having worked with the Elemental team​ ​and having such a high level of inter-dependency we expect this will ease the integration process.”

Elemental has been ​the ​distributor for SI branded products since its inception in 2007​. It also handles UK​ ​distribution of Microline Surgical​'s complementary range of laparoscopic instruments, bariatric products on​ ​behalf of GI Dynamics, hernia repair products for Cousin Biotech and P​e​ters Surgical, and breast​ ​reconstruction products for Meccellis Biotech.

Over the last year the combined businesses would have produced annual sales of around £12m and a pre-tax profit of around £1.4m. Eric Burns, ​d​irector of ​r​esearch at WH Ireland, said: “We have argued for some​ ​time that Surgical Innovations offers investors a platform for building a much larger healthcare business on​ ​AIM and the Elemental deal is a major first step in this direction.

With the substantial resources of a PLC​ ​owner behind it we think there’s good scope for Elemental to significantly increase its product portfolio as​ ​well as bringing a direct sales force to Surgical from day one.” In March, Surgical announced a​n 11 per cent increase in annual sales to £6.1m​,​ mainly driven by favourable export​ ​conditions in what the group described at the time as a breakout year. Results for 2016 marked a return to ​the ​black with a £280,000 profit compared ​with​ a pre-tax loss of £2.1m in​ ​2015. The share price fell initially in reaction to the discounted placing to 3.25p before recovering later in the day​ ​to finish ​at 3.5​8p.












clues

Microline Surgical
50 Dunham Road, Suite 1500
Beverly, MA 01915 USA

buywell3
Chat Pages: Latest  417  416  415  414  413  412  411  410  409  408  407  406  Older

Your Recent History

Delayed Upgrade Clock